Mitsubishi UFJ Trust & Banking Corp Has $37.06 Million Holdings in Cardinal Health, Inc. (NYSE:CAH)

Mitsubishi UFJ Trust & Banking Corp cut its holdings in shares of Cardinal Health, Inc. (NYSE:CAH) by 2.6% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 313,327 shares of the company’s stock after selling 8,484 shares during the quarter. Mitsubishi UFJ Trust & Banking Corp’s holdings in Cardinal Health were worth $37,057,000 as of its most recent SEC filing.

Several other institutional investors have also made changes to their positions in the stock. TIAA Trust National Association lifted its position in shares of Cardinal Health by 4.5% during the 4th quarter. TIAA Trust National Association now owns 2,183 shares of the company’s stock valued at $258,000 after acquiring an additional 94 shares during the period. CoreFirst Bank & Trust bought a new stake in Cardinal Health during the fourth quarter worth about $62,000. Stevens Capital Management LP acquired a new stake in Cardinal Health during the fourth quarter worth about $265,000. LPL Financial LLC increased its holdings in Cardinal Health by 6.7% in the 4th quarter. LPL Financial LLC now owns 231,276 shares of the company’s stock valued at $27,353,000 after buying an additional 14,623 shares during the period. Finally, Simplify Asset Management Inc. acquired a new position in shares of Cardinal Health in the 4th quarter valued at approximately $718,000. 87.17% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

A number of research analysts recently issued reports on the stock. TD Cowen raised shares of Cardinal Health from a “hold” rating to a “buy” rating and lifted their price objective for the company from $130.00 to $144.00 in a research note on Wednesday, January 8th. Bank of America raised Cardinal Health from a “neutral” rating to a “buy” rating and boosted their price target for the stock from $132.00 to $145.00 in a report on Monday, January 6th. Morgan Stanley raised their price objective on Cardinal Health from $136.00 to $142.00 and gave the company an “overweight” rating in a research note on Friday, January 31st. JPMorgan Chase & Co. boosted their target price on Cardinal Health from $142.00 to $145.00 and gave the stock a “neutral” rating in a research note on Tuesday, February 4th. Finally, Argus set a $148.00 price target on shares of Cardinal Health in a report on Tuesday, February 4th. Four analysts have rated the stock with a hold rating and eleven have given a buy rating to the company. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $139.36.

Cardinal Health Stock Up 0.9 %

NYSE CAH opened at $133.91 on Thursday. The company has a market capitalization of $32.35 billion, a price-to-earnings ratio of 24.98, a PEG ratio of 1.49 and a beta of 0.66. Cardinal Health, Inc. has a twelve month low of $93.17 and a twelve month high of $134.86. The stock has a fifty day simple moving average of $127.96 and a 200 day simple moving average of $120.48.

Cardinal Health (NYSE:CAH) last issued its quarterly earnings results on Thursday, January 30th. The company reported $1.93 earnings per share for the quarter, beating the consensus estimate of $1.74 by $0.19. Cardinal Health had a negative return on equity of 59.57% and a net margin of 0.59%. Research analysts expect that Cardinal Health, Inc. will post 7.95 earnings per share for the current fiscal year.

Cardinal Health Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, April 15th. Stockholders of record on Tuesday, April 1st will be given a $0.5056 dividend. The ex-dividend date of this dividend is Tuesday, April 1st. This represents a $2.02 dividend on an annualized basis and a dividend yield of 1.51%. Cardinal Health’s dividend payout ratio (DPR) is currently 37.69%.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.